Bioharvest Sciences Inc.
BHST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723464
No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Bioharvest Sciences Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 0 | 6 | +6 |
| Shares | 0 | 89.1K | +89.1K |
| Value | $0 | $545.4K | +$545.4K |
New holders (6)
Institutions that held Bioharvest Sciences Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| True North Advisors, LLC | 41,271 | $255.1K | 0.06% |
| Magnus Financial Group LLC | 35,000 | $216.3K | 0.02% |
| TD Waterhouse Canada Inc. | 12,042 | $69.0K | 0.00% |
| Advisor Group Holdings, Inc. | 628 | $3.88K | 0.00% |
| National Bank of Canada | 110 | $674 | 0.00% |
| Federation des caisses Desjardins du Quebec | 76 | $435 | 0.00% |
Sold out (0)
Institutions that held Bioharvest Sciences Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
None.